IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

Nature Immunology

Volumn 1, Issue 6, 2000, Pages 510-514

  Chomarat, Pascale ^a   Banchereau, Jacques ^a   Davoust, Jean ^a   Palucka, A Karolina ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 6;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; COCULTURE; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MACROPHAGE; METABOLISM; MONOCYTE;

ANTIGENS, CD14; CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 0034577943     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/82763     Document Type: Article

References (18)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296 (1991).
2. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
3. Banchereau, J. et al. Immunobiology of dendritic cells. Ann. Rev. Immunol. 8, 767-811 (2000).
4. Becker, S., Warren, M. K. & Haskill, S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J. Immunol. 139, 3703-3709 (1987).
5. Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93 (1994).
6. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179, 1109-1118 (1994).
7. + dendritic cells. Proc. Natl Acad. Sci. USA 93, 2588-2592 (1996).
8. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. & Gluckman, J. C. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160, 4587-4595 (1998).
9. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M. & Muller, W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-433 (1998).
10. Mekori, Y. A. & Metcalfe, D. D. Mast cells in innate immunity. Immunol. Rev. 173, 131-140 (2000).
11. Yamasaki, K. et al. Cloning and expression of the human interleukin-6 (BSF-2/IFN-β2) receptor. Science 241, 825-828 (1988).
12. Hibi, M. et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63, 1149-1157 (1990).
13. Peters, M. et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the half-life of IL-6. J. Exp. Med. 183, 1399-1406 (1996).
14. + progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791 (1998).
15. Micani, H. et al. Activity of inrerteukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br. J. Haematol. 109, 288-295 (2000).
16. Kopf, M. et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342 (1994).
17. Ladel, C.H. et al. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65, 4843-4849 (1997).
18. Tanaka, T. et al. Targeted disruption of the NF-IL6 gene disclosed its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361 (1995).